Cancer (MSc)

The Cancer MSc is a programme designed to reflect the depth and breadth of research within the UCL Cancer Institute, which has recently achieved 'CR-UK Centre' status. The programme, taught by research scientists and academic clinicians, provides students with an in-depth study of the biology behind the disease processes which lead to cancer. What and how will I learn? This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor, and treat cancer, alongside the cutting edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies. Degree Structure Students undertake courses to the value of 180 credits. The programme consists of two core modules (60 credits), three optional modules (60 credits) and a research project (60 credits). A Postgraduate Diploma (120 credits, full-time nine months) is offered. Core Modules Basic Biology and Cancer Genetics Cancer Therapeutics Dissertationreport All MSc students undertake a laboratory project, clinical trials project or systems biologyinformatics project, which culminates in a 10,000 - 12,000 word dissertation and an oral presentation. Options Phase I Experimental Medicine & Clinical Trials Radiation Biology and Therapy Gene Therapy in Cancer Cancer Epigenetics Cancer Therapeutics: Bench to Bedside Molecular Pathology and Genomics Haematological Malignancies Evidence-Based Cancer Medicine Behavioural Science and Cancer Further details available on subject website: http:www.ucl.ac.ukcancermsc-cancer Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based experimentsstudies, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written exam (50%) and coursework (50%). The research project is assessed by the dissertation and oral presentation. Why should I study this degree at UCL? UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research. The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, epigenetic changes in cancer, gene therapy, early phase clinical trials and national and international clinical trials in solid tumours and blood cancers. Your future career The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer. Entry Requirements A minimum of an upper second-class Bachelor's degree in a relevant discipline from a UK university or an overseas qualification of an equivalent standard. How to apply Due to competition for places candidates are advised to apply as early as possible. For those students working to organise scholarship funding (particularly overseas applicants), early application for admission is strongly encouraged, preferably by 1 January for the following academic year. Who can apply? The programme is designed for those with qualifications in life sciences, scientists, clinicians, and other healthcare professionals including individuals from the pharmaceutical and biotech industries. The knowledge and transferable skills developed are suitable for those in an industrial or healthcare setting, and for students contemplating further PhD or medical studies. RAE Rating Cancer Institute 75% rated 4* (world-leading) or 3* (internationally excellent) http:www.ucl.ac.ukgradprospectuscancer

The Cancer MSc is a programme designed to reflect the depth and breadth of research within the UCL Cancer Institute, which has recently achieved 'CR-UK Centre' status. The programme, taught by research scientists and academic clinicians, provides students with an in-depth study of the biology behind the disease processes which lead to cancer. What and how will I learn? This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students lea...